Charles Ross Carter - 06 Jul 2026 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Reporting relationship: Chief Financial Officer
Issuer ticker: OVID
Reported as of: 06 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2026, 16:31:44 UTC
Prior SEC filing: 01 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Charles Carter

Key filing fact

Charles Ross Carter filed Form 4 for Ovid Therapeutics Inc. (OVID) on 08 Jul 2026.

Key facts

This page summarizes Charles Ross Carter's Form 4 filing for Ovid Therapeutics Inc. (OVID).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jul 2026, 16:31.

Change

Previous filing in this sequence was filed on 01 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001779359 Primary reporting owner

Carter Charles Ross

Relationship: Chief Financial Officer
Address: C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, 14TH FLOOR, NEW YORK
Signature: /s/ Charles Carter
Signature date: 08 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OVID transaction

Common Stock

Award

Transaction value
Shares: +50,000
Change %: +113%
Price: $0.000000^*
Shares after: 94,375
Date: 06 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. The RSUs will vest in two equal annual installments commencing on July 6, 2027, subject to the Reporting Person's continuous service through each such vesting date.

Footnote F2

Each RSU represents a contingent right to receive one share of Common Stock.